Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF Inhalation for Nontuberculous Mycobacterial Lung Disease Pilot Trial
jRCTs031210062Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of sargramostim in nontuberculous mycobacterial lung disease (3 arms), sponsored by Japan Agency for Medical Research and Development. Started Sep 2021; status: completed.
02
Drugs
sargramostim
03
Conditions
nontuberculous mycobacterial lung disease
Beyond the preview
Go deeper on jRCTs031210062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210062.